Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor

American Journal of Surgical Pathology

Volumn 32, Issue 2, 2008, Pages 256-260

  Devilliers, Patricia ^a,f   Liu, Hao ^b   Suggs, Cynthia ^c   Simmons, Darrin ^c   Daly, Bill ^c   Zhang, Shaoping ^c   Raubenheimer, Erich ^d   Larsson, Åke ^e   Wright, Tim ^b  

^a University of Alabama at Birmingham   (United States)

^b Tianjin Union Medical Centre   (China)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF LIMPOPO   (South Africa)

^e MALMÖ UNIVERSITY   (Sweden)

^f Department of Pathology PD6A 149E ^*  (United States)

Author keywords

Ameloblastoma; Calretinin; Keratocystic odontogenic tumor

Indexed keywords

CALRETININ;

AMELOBLASTOMA; ARTICLE; BASAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; ODONTOGENIC KERATOCYST; PROTEIN EXPRESSION;

AMELOBLASTOMA; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; JAW NEOPLASMS; ODONTOGENIC CYSTS; ODONTOGENIC TUMORS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 38649142844     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181452176     Document Type: Article

References (28)

1. Afework M, Burnstock G. Calretinin immunoreactivity in adrenal glands of developing, adult and ageing Sprague-Dawley rats. Int J Dev Neurosci. 1995;13:515-521.
2. Altini M, Coleman H, Doglioni C, et al. Calretinin expression in ameloblastomas. Histopathology. 2000;37:27-32.
3. Andressen C, Blumcke I, Celio MR. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res. 1993;271:181-208.
4. Barnes L, Eveson J, Reichart P, et al. Pathology and Genetics of Head and Neck Tumors. Switzerland: WHO Press; 2005.
5. Bertschy S, Genton CY, Gotzos V. Selective immunocytochemical localization of calretinin in the human ovary. Histochem Cell Biol. 1998;109:59-66.
6. Brockstedt U, Gulyas M, Dobra K, et al. An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol. 2000;114:203-209.
7. Carella R, Deleonardi G, D'Errico A, et al. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis. Am J Surg Pathol. 2001;25:43-50.
8. Chenard-Neu MP, Kabou A, Mechine A, et al. Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma. Evaluation of 5 new antibodies and 6 traditional antibodies. Ann Pathol. 1998;18:460-465.
9. Cury PM, Butcher DN, Fisher C, et al. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol. 2000;13:107-112.
10. Doglioni C, Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol. 1996;20:1037-1046.
11. Dunsche A, Babendererde O, Luttges J, et al. Dentigerous cyst versus unicystic ameloblastoma - differential diagnosis in routine histology. J Oral Pathol Med. 2003;32:486-491.
12. Gangji V, Krebs C, Rooze M, et al. Calretinin is transiently expressed in tendon fibroblasts of the paravertebral region of the chick embryo. Eur J Morphol. 1997;35:137-142.
13. Gardner DG, O'Neill PA. Inability to distinguish ameloblastomas from odontogenic cysts based on expression of blood cell carbohydrates. Oral Surg Oral Med Oral Pathol. 1988;66:480-482.
14. Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore). 1987;66:98-113.
15. Gotzos V, Wintergerst ES, Musy JP, et al. Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues. Am J Surg Pathol. 1999;23:701-711.
16. Heizmann CW. Calcium-binding proteins: basic concepts and clinical implications. Gen Physiol Biophys. 1992;11:411-425.
17. Kiraly E, Celio MR. Parvalbumin and calretinin in the avian thymus. Anat Embryol (Berlin). 1993;188:339-344.
18. Matsuno Y, Morozumi N, Hirohashi S, et al. Papillary carcinoma of the thymus: report of four cases of a new microscopic type of thymic carcinoma. Am J Surg Pathol. 1998;22:873-880.
19. Mistry D, Altini M, Coleman HG, et al. The spatial and temporal expression of calretinin in developing rat molars (Rattus norvegicus). Arch Oral Biol. 2001;46:973-981.
20. Neville BW, Damm D, Allen C, et al. Oral & Maxillofacial Pathology. USA: W. B. Saunders Company; 2002.
21. Oates J, Edwards C. HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology. 2000;36:341-347.
22. Ordonez NG. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Mod Pathol. 1998;11:929-933.
23. Ordonez NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol. 2007;38:1-16.
24. Parmentier M, Lefort A. Structure of the human brain calcium-binding protein calretinin and its expression in bacteria. Eur J Biochem. 1991;196:79-85.
25. Piattelli A, Fioroni M, Iezzi G, et al. Calretinin expression in odontogenic cysts. J Endod. 2003;29:394-396.
26. Rogers JH. Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol. 1987;105:1343-1353.
27. Schwaller B, Buchwald P, Blumcke I, et al. Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium. 1993;14:639-648.
28. Strauss KI, Isaacs KR, Ha QN, et al. Calretinin is expressed in the Leydig cells of rat testis. Biochim Biophys Acta. 1994;1219:435-440.